Cover Image

Correction: Nulsopapon et al. The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Isolates. <i>Antibiotics</i> 2021, <i>10</i>, 736

There were errors made in the original article [...]

Saved in:

Bibliographic Details
Main Authors:	Parnrada Nulsopapon (Author), Worapong Nasomsong (Author), Manat Pongchaidecha (Author), Dhitiwat Changpradub (Author), Piraporn Juntanawiwat (Author), Wichai Santimaleeworagun (Author)
Format:	Book
Published:	MDPI AG, 2022-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant <em>Klebsiella pneumoniae</em> Isolates
by: Parnrada Nulsopapon, et al.
Published: (2021)

Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Worapong Nasomsong, et al.
Published: (2022)

Antimicrobial Activity Profiles and Potential Antimicrobial Regimens against Carbapenem-Resistant Enterobacterales Isolated from Multi-Centers in Western Thailand
by: Parnrada Nulsopapon, et al.
Published: (2022)

The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant Klebsiella pneumoniae Clinical Isolates Harboring Different Carbapenemase Types in a Thai University Hospital
by: Nasomsong W, et al.
Published: (2021)

Does Vancomycin Resistance Increase Mortality? Clinical Outcomes and Predictive Factors for Mortality in Patients with <i>Enterococcus faecium</i> Infections
by: Jatapat Hemapanpairoa, et al.
Published: (2021)

Is Early Monitoring Better? Impact of Early Vancomycin Exposure on Treatment Outcomes and Nephrotoxicity in Patients with Methicillin-Resistant <i>Staphylococcus aureus</i> Infections
by: Thanawat Chattaweelarp, et al.
Published: (2020)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021)

Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Clinical Strains: A Challenge for Tertiary Care Hospitals
by: Aamir Jamal Gondal, et al.
Published: (2024)

Genetic Determinants of Tigecycline Resistance in <i>Mycobacteroides abscessus</i>
by: Hien Fuh Ng, et al.
Published: (2022)

Bacteriostatic and Bactericidal Effect of Tigecycline on <i>Leptospira</i> spp.
by: Fabrizio Bertelloni, et al.
Published: (2020)

Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021)

Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant <i>Escherichia coli</i> Harboring <i>bla</i><sub>NDM-1</sub> and <i>bla</i><sub>NDM-5</sub>
by: Pawarisa Terbtothakun, et al.
Published: (2021)

Effectiveness and resource utilization of hospital-based contact tracing of patients and health care workers with COVID-19 at a tertiary teaching hospital in Thailand
by: Worapong Nasomsong, et al.
Published: (2023)

Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>: A Propensity Score-Matched Cohort Study
by: Lei Zha, et al.
Published: (2023)

The Characterisation of Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> in a Teaching Hospital in Malaysia
by: Min Yi Lau, et al.
Published: (2024)

Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and Carbapenem-Resistant <i>Escherichia coli</i>
by: Kamonchanok Jitaree, et al.
Published: (2019)

Efficacy of Tamoxifen Metabolites in Combination with Colistin and Tigecycline in Experimental Murine Models of <i>Escherichia coli</i> and <i>Acinetobacter baumannii</i>
by: Soraya Herrera-Espejo, et al.
Published: (2024)

Antimicrobials as Single and Combination Therapy for Colistin-Resistant <i>Pseudomonas aeruginosa</i> at a University Hospital in Thailand
by: Supanun Pungcharoenkijkul, et al.
Published: (2020)

Co-Occurrence of β-Lactam and Aminoglycoside Resistance Determinants among Clinical and Environmental Isolates of <i>Klebsiella pneumoniae</i> and <i>Escherichia coli</i>: A Genomic Approach
by: Hisham N. Altayb, et al.
Published: (2022)

The Role of Subinhibitory Concentrations of Daptomycin and Tigecycline in Modulating Virulence in <i>Staphylococcus aureus</i>
by: Salman Sahab Atshan, et al.
Published: (2021)

Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in <i>Acinetobacter baumannii</i>
by: Hyejin Cho, et al.
Published: (2023)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>
by: Paraskevi Mantzana, et al.
Published: (2023)

First Detection of High-Level Aminoglycoside-Resistant <i>Klebsiella pneumoniae</i> and <i>Enterobacter cloacae</i> Isolates Due to 16S rRNA Methyltransferases with and Without <i>bla</i><sub>NDM</sub> in Uruguay
by: Romina Papa-Ezdra, et al.
Published: (2024)

Ciprofloxacin and Tetracycline Resistance Cause Collateral Sensitivity to Aminoglycosides in <i>Salmonella</i> Typhimurium
by: Mahadi Hasan, et al.
Published: (2023)

A Randomized Controlled Trial of Colistin Combined with Sulbactam: 9 g per Day versus 12 g per Day in the Treatment of Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Pneumonia: An Interim Analysis
by: Chutchawan Ungthammakhun, et al.
Published: (2022)

Clinical Impact of Vancomycin Treatment in Ampicillin-Susceptible Enterococci Bloodstream Infections
by: Jatapat Hemapanpairoa, et al.
Published: (2022)

Metformin Reverses <i>tmexCD1-toprJ1</i>- and <i>tet</i>(A)-Mediated High-Level Tigecycline Resistance in <i>K. pneumoniae</i>
by: Xia Xiao, et al.
Published: (2022)

Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in COVID-19 Era-Challenges and Solutions
by: Jozef Ficik, et al.
Published: (2023)

Disinfection Strategies for Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in a Healthcare Facility
by: Lijia Ni, et al.
Published: (2022)

High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and <i>Acinetobacter baumannii</i>
by: Massimiliano De Angelis, et al.
Published: (2022)

Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i> in an Academic Medical Center in Thailand
by: Taniya Paiboonvong, et al.
Published: (2022)

Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, <i>Acinetobacter baumannii</i>: A Multicenter Study in China
by: Xuemei Zhen, et al.
Published: (2020)

Discovery of Novel Resistance Mechanisms of <i>Vibrio parahaemolyticus</i> Biofilm against Aminoglycoside Antibiotics
by: Cuifang Tian, et al.
Published: (2023)

Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant <i>Klebsiella pneumoniae</i> Pneumonia-Septicemia Model in Rats
by: Hessel Van der Weide, et al.
Published: (2020)

Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Clinical Isolates: In Vivo Virulence Assessment in <i>Galleria mellonella</i> and Potential Therapeutics by Polycationic Oligoethyleneimine
by: Dalila Mil-Homens, et al.
Published: (2021)

Genetic Characterization of Carbapenem-Resistant <i>Klebsiella</i> spp. from Municipal and Slaughterhouse Wastewater
by: Mykhailo Savin, et al.
Published: (2022)

Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant <i>Klebsiella pneumoniae</i>
by: Tsung-Ying Yang, et al.
Published: (2021)

Impact of Tigecycline's MIC in the Outcome of Critically Ill Patients with Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Bacteraemia Treated with Tigecycline Monotherapy-Validation of 2019's EUCAST Proposed Breakpoint Changes
by: Matthaios Papadimitriou-Olivgeris, et al.
Published: (2020)

A New <i>Casjensviridae</i> Bacteriophage Isolated from Hospital Sewage for Inactivation of Biofilms of Carbapenem Resistant <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Sambuddha Chakraborty, et al.
Published: (2024)

Aminoglycoside 6'-<i>N</i>-acetyltransferase Type Ib [AAC(6')-Ib]-Mediated Aminoglycoside Resistance: Phenotypic Conversion to Susceptibility by Silver Ions
by: Craig M. Reeves, et al.
Published: (2020)